Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/16/2025

Cold Sore Treatment Guidelines

Application Schedule

  • Apply Abreva (docosanol 10% cream) five times daily for 5 days, starting at the first sign of a cold sore, as recommended by the Journal of Clinical Virology guidelines 1, 2
  • Apply 5 times per day at approximately equal intervals throughout waking hours, following the application schedule outlined by the Journal of Clinical Virology 1, 2
  • Continue treatment for 5 days, even if symptoms resolve earlier, as advised by the Journal of Clinical Virology 1, 2
  • Treatment must be initiated at the earliest sign of recurrence (prodromal symptoms) to achieve optimal benefit, according to the Journal of Clinical Virology guidelines 1, 2

Critical Timing Considerations

  • Peak viral replication occurs within the first 24 hours of lesion onset, making early application essential for any therapeutic benefit, as reported by the Journal of Clinical Virology 1
  • The natural healing process begins within 24 hours of episode onset, creating a narrow window of therapeutic opportunity, as noted by the Journal of Clinical Virology 1
  • Delayed treatment initiation significantly reduces effectiveness, as demonstrated by the Journal of Clinical Virology 1, 2

Evidence for Efficacy and Important Caveats

  • OTC topical antivirals applied multiple times daily provide only small clinical benefit by modestly reducing symptom duration, as found by the Journal of Clinical Virology 1, 2
  • Topical antivirals do not impact the host immune response or inflammatory cascade, as reported by the Journal of Clinical Virology 1, 2
  • Oral antiviral therapy (acyclovir, famciclovir, or valaciclovir) is more effective than topical agents for recurrent herpes labialis, decreasing outbreak duration and pain by approximately 1 day, according to the Journal of Clinical Virology 1, 2

Alternative Considerations

  • Short-course, high-dose oral antiviral therapy offers superior convenience and efficacy compared to frequent topical application, as recommended by the Journal of Clinical Virology 1, 2